Summary
Strive: Strategic Expansion Meets Bitcoin Tailwinds -- Set For A Solid 2025 Finish
Strive Asset Management, LLC is acquiring Semler Scientific, boosting its Bitcoin holdings to 10,900 coins and becoming a top-12 BTC treasury company. The all-stock deal offers a 210% premium to SMLR shareholders and creates a combined entity with $1.25 billion in Bitcoin at current prices. ASST trades at a 24% discount to its pro forma Bitcoin holdings, supporting a bullish outlook and a 12-month price target of $1.70 (23% upside).
Semler Scientific, Inc. (SMLR) Q2 2025 Earnings Call Transcript
Semler Scientific, Inc. (NASDAQ:SMLR ) Q2 2025 Earnings Conference Call August 4, 2025 4:30 PM ET Company Participants Douglas Murphy-Chutorian - CEO, President & Director Eric H. Semler - Executive Chairman of the Board Joe Burnett - Corporate Participant Renae Cormier - CFO, Head of Corp. Communications & Bus.
Semler Scientific, Inc. (SMLR) Q1 2025 Earnings Call Transcript
Semler Scientific, Inc. (NASDAQ:SMLR ) Q1 2025 Earnings Conference Call May 13, 2025 4:00 PM ET Company Participants Doug Murphy-Chutorian - CEO Eric Semler - Chairman Jennifer Oliva Herrington - COO Renae Cormier - CFO Operator Good afternoon and welcome to the Semler Scientific First Quarter 2025 Financial Results Conference Call. All participants will be in a listen-only mode.
Semler Scientific Inc. (SMLR) FAQ
What is the stock price today?
On which exchange is it traded?
What is its stock symbol?
Does it pay dividends? What is the current yield?
What is its market cap?
When is the next earnings date?
Has Semler Scientific Inc. ever had a stock split?
Semler Scientific Inc. Profile
| Health Care Equipment & Supplies Industry | Healthcare Sector | Douglas Murphy-Chutorian CEO | NASDAQ (CM) Exchange | 81684M104 CUSIP |
| US Country | 79 Employees | - Last Dividend | - Last Split | 21 Feb 2014 IPO Date |
Overview
Semler Scientific, Inc., based in Santa Clara, California, is a technology company focused on providing advanced solutions to enhance the clinical operations and effectiveness of healthcare providers across the United States. Incorporated in 2007, Semler Scientific lays emphasis on innovating and distributing products that aid in the assessment and management of vascular conditions and diabetes care. Their client base encompasses a wide range of healthcare professionals and organizations, including cardiologists, internists, nephrologists, endocrinologists, podiatrists, and family practitioners, as well as healthcare insurance plans, integrated delivery networks, independent physician groups, and companies in the healthcare industry such as risk assessment groups and retailers. Distribution is achieved through a combination of direct sales representatives and distributors, ensuring their cutting-edge products are accessible to a broad spectrum of healthcare providers.
Products and Services
-
QuantaFlo:
This product stands out as a quick and efficient in-office test designed to measure blood flow, taking only about four minutes to complete. QuantaFlo's technology enables healthcare providers to easily incorporate blood flow measurements into their examination process, aiding in the assessment of a patient's vascular health. This tool is particularly useful for professionals aiming to diagnose and manage vascular conditions with greater accuracy and speed.
-
Insulin Insights:
A sophisticated software program, Insulin Insights is crafted to assist healthcare providers in optimizing insulin dosing for outpatients. By utilizing this tool, medical practitioners can achieve more precise and individualized insulin dose recommendations, enhancing the overall management of diabetes. This program underscores Semler Scientific's commitment to supporting healthcare providers in delivering better diabetes care, by leveraging advanced technology to improve treatment outcomes for patients.
Contact Information
